These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [On the detection of sulfonamide crystals in the kidney]. Theiss E; Studer A; Waldmann H Arzneimittelforschung; 1965 Nov; 15(11):1352-5. PubMed ID: 5899873 [No Abstract] [Full Text] [Related]
65. [Ceftriaxone-associated pseudolithiasis in children]. Zhang L; Yao Y Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):877-8. PubMed ID: 19099914 [No Abstract] [Full Text] [Related]
66. [Urinary concrements due to long-term sulfonamides]. Otto H; von Allesch Urologe; 1969; 8(4):202-4. PubMed ID: 5359382 [No Abstract] [Full Text] [Related]
67. Ascorbic acid and kidney stones. Hoffer A Can Med Assoc J; 1985 Feb; 132(4):320. PubMed ID: 3971246 [No Abstract] [Full Text] [Related]
68. [Silicates and renal calculi]. Lunde I Tidsskr Nor Laegeforen; 1971 Dec; 91(35):2574-5. PubMed ID: 4333175 [No Abstract] [Full Text] [Related]
69. [Porphyrins in triamterene calculi]. Traba ML; Perpiñá J; Enríquez de Salamanca R Arch Esp Urol; 1987 Mar; 40(2):105-6. PubMed ID: 3592770 [No Abstract] [Full Text] [Related]
70. Triamterene urolithiasis. Gault MH; Snedden W; Taor RE; Churchill DN; Ahmed M Can Med Assoc J; 1981 Jun; 124(12):1556-7. PubMed ID: 7248862 [No Abstract] [Full Text] [Related]
71. Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity. Hagos Y; Wolff NA Toxins (Basel); 2010 Aug; 2(8):2055-82. PubMed ID: 22069672 [TBL] [Abstract][Full Text] [Related]
72. [Clinical strategies for prevention of drug-induced urinary calculi]. Kohjimoto Y; Sasaki Y; Hara I Clin Calcium; 2011 Oct; 21(10):1457-63. PubMed ID: 21960230 [TBL] [Abstract][Full Text] [Related]
73. [Drug-induced urinary calculi in 1999]. Daudon M Prog Urol; 1999 Dec; 9(6):1023-33. PubMed ID: 10658246 [TBL] [Abstract][Full Text] [Related]
74. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate). Conte A; Pizá P; García-Raja A Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897 [TBL] [Abstract][Full Text] [Related]
77. [Vitamin C and stone risk. Review of the literature]. Traxer O; Pearle MS; Gattegno B; Thibault P Prog Urol; 2003 Dec; 13(6):1290-4. PubMed ID: 15000301 [TBL] [Abstract][Full Text] [Related]